Updates
Accelerate Diagnostics, Inc. announced the election of Charles Watts, M.D. to the company’s board of directors. His appointment is effective November 14, 2017.

Nov 16, 2017 — Dr. Watts has held a number of clinical and administrative leadership positions at two renowned academic medical centers, Northwestern (Feinberg School of Medicine, Northwestern Memorial Hospital) and the University of Michigan, and with his training and extensive clinical career as a Pulmonary-Critical Care specialist, he adds a comprehensive background of clinical practice and healthcare administration to […]

Continue reading


New from LabRoots: Dr. Margie Morgan to present on the impact of fast phenotypic susceptibility results to laboratory workflow and patient outcomes

Nov 09, 2017 — Dr. Margie Morgan, Scientific Director Microbiology at Cedars-Sinai Medical Center, is scheduled to present on the impact that fast phenotypic antibiotic susceptibility results have to laboratory workflow and patient outcomes at the LabRoots Clinical Diagnostics and Research Virtual Event, November 9th at 12:30 p.m. ET.

Continue reading


Accelerate Diagnostics reports Q3 2017 financial results

Nov 02, 2017 — Accelerate Diagnostics, Inc. today announced preliminary financial results for the quarter ending September 30, 2017. The company further reported signed agreements for 295 instruments year to date; contracts for customer evaluations total 239 instruments while revenue generating placements grew to 56 across the U.S., European, and Middle East regions.

Continue reading


Third Quarter 2017 Conference Call Set for November 2nd

Oct 17, 2017 — Accelerate Diagnostics, Inc. will announce third quarter 2017 financial results at the close of U.S. financial markets on Thursday, November 2, 2017.

Continue reading


See all news

See the Latest data from IDWeek™

See the Latest data from ASM


Media kit

Media contact

Andy Chasteen
520.365.3100
achasteen@axdx.com


Company information

About the company
Bios
Our products


Digital assets

Enter your email address below for access to photos, logos and videos.

See Terms and Use Policy


Connect with us

  Like us on Facebook
  Follow us on Twitter
  See us on Linkedin
  Visit us on Google+

Upcoming Events
SCCM 2018

February 25-28, 2018
San Antonio, TX

Learn more

RICAI 2017

December 18-19, 2017
Palais des Congrès de Paris

Learn more

Want to hear when we announce our next event?

Stay up to date with Accelerate by joining our mailing list.

Sign up today
Past Events
IDWeek 2017

October 4–8, 2017
San Diego

Learn more

ASM Microbe 2017

June 1–5, 2017
New Orleans

Learn more

MAD-ID Annual Meeting

May 10–13, 2017
Orlando, FL

Learn more

AMMI/CACMID 2017

Friday, May 5, 2017
Toronto

Learn more

ECCMID 2017

April 22–25, 2017
Vienna, Austria

Learn more

CLMA 2017

March 26–28, 2017
Nashville, TN

Learn more

Over the past several years, Accelerate Diagnostics, together with our scientific collaborators, conducted numerous scientific studies supporting the exciting capabilities of our ID/AST System. Many of these studies resulted in posters presented at international conferences and peer-reviewed publications. We have conducted over 87,000 internal identification and susceptibility experiments across a panel of more than 20 of the most clinically prevalent species in sample types such as positive blood cultures and BALs. These studies demonstrated compelling performance versus reference and comparator methods, the results of which have been consistently duplicated by our clinical research partners. Below you will find links to some of these posters and publications.


These publications may include information from one or more organism/antimicrobial combinations that are research use only and not for use in diagnostic procedures.

Certain uses of devices included in these publications may not have been approved or cleared by the U.S. Food and Drug Administration or other regulatory bodies.

See product labeling for instructions for use, warnings, and limitations specific to each product and region.

Okay, I understand. Show me the publications.